Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flow (Unaudited)

v3.23.2
Condensed Consolidated Statements of Cash Flow (Unaudited) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Cash flows from operating activities:          
Net income (loss) from continuing operations, including noncontrolling interest $ 1,284,568 $ (499,841) $ 2,090,128 $ (2,765,973)  
Adjustments to reconcile net income (loss) to net cash used in operations:          
Depreciation and amortization 99,357 117,216 193,492 234,040  
Loss on disposition of property and equipment     858  
Net (gain) loss from legal settlements 276,313 76,218 (286,719) 76,218  
Gain on forgiveness of debt (200,000) (334,819) (200,000) (334,819)  
Loss from discontinued operations     (8,097) (5,379)  
Changes in operating assets and liabilities:          
Accounts receivable     229,819 186,131  
Inventory     7,280 36,890  
Prepaid expenses and other current assets     (168,159) 21,304  
Security deposits     1,117 (10,000)  
Change in right-of-use assets     133,946 117,871  
Accounts payable     1,494,659 484,458  
Accrued expenses     (531,720) 867,828  
Income taxes payable     517,000  
Change in right-of-use operating lease obligations     (133,946) (117,871)  
Net cash provided by (used in) operating activities of continuing operations     3,338,800 (1,208,444)  
Net cash provided by (used in) operating activities of discontinued operations     8,097 (1,714)  
Net cash provided by (used in) operating activities     3,346,897 (1,210,158)  
Cash flows from investing activities:          
Receivable from related party     (876,998) (428,943)  
Purchases of property and equipment     (276,983) (33,940)  
Net cash used in investing activities of continuing operations     (1,153,981) (462,883)  
Cash flows from financing activities:          
Proceeds from issuance of related party loan payable     580,000 750,000  
Payments of related party loan payable     (1,322,000)  
Payments of debentures     (400,000)  
Payments of notes payable     (824,869) (1,171,603)  
Receivables paid under accounts receivable sales agreements     (317,647)  
Proceeds from issuances of preferred stock     1,500,000  
Proceeds from HHS Provider Relief Funds     314,651  
Cash paid for fractional shares in connection with reverse stock split     (9)  
Net cash (used in) provided by financing activities of continuing operations     (1,966,869) 1,075,392  
Net change in cash     226,047 (597,649)  
Cash at beginning of period     499,470 724,524 $ 724,524
Cash at end of period $ 725,517 $ 126,875 $ 725,517 $ 126,875 $ 499,470